What 4 Analyst Ratings Have To Say About Ingredion
Portfolio Pulse from Benzinga Insights
Over the past three months, four analysts have evaluated Ingredion (NYSE: INGR), with ratings ranging from bullish to indifferent. The average 12-month price target has increased by 9.82% to $139.75. Analysts from UBS, Barclays, BMO Capital, and Oppenheimer have raised their price targets, reflecting positive sentiment despite recent revenue challenges.
August 15, 2024 | 2:01 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Analysts have shown a mixed but generally positive sentiment towards Ingredion (NYSE: INGR) over the past three months. The average 12-month price target has increased by 9.82% to $139.75, with recent ratings from UBS, Barclays, BMO Capital, and Oppenheimer all being bullish.
The increase in the average price target and the bullish ratings from multiple analysts suggest a positive short-term outlook for Ingredion. Despite recent revenue challenges, the company's strong net margin, ROE, and ROA indicate robust financial health, which likely influenced the analysts' positive revisions.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100